Prediction Model of Ki67 Proliferation Level in Hepatocellular Carcinoma Based on Contrast‐Enhanced Ultrasound
- 8 August 2025
- journal article
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 54 (1) , 43-52
Abstract
Objective: To investigate the correlation between contrast‐enhanced ultrasound (CEUS) features and Ki‐67 expression in patients with hepatocellular carcinoma (HCC). Methods: It was a retrospective analysis involving 94 patients with HCC receiving surgeries and diagnosed by postoperative pathology from January 2020 to December 2021. All patients were examined by preoperative CEUS and postoperative Ki‐67 immunohistochemistry. Divided by the cut‐off of the Ki‐67 labeling index, HCC patients were assigned into the low ( n = 46) and high Ki‐67 expression groups ( n = 48). Clinical data and imaging features of CEUS were compared between groups. Finally, a CEUS‐based model in predicting abnormal Ki‐67 expression in HCC was created. Results: Significant differences showed in the age of onset, alpha fetoprotein (AFP), des‐gamma‐carboxy prothrombin (DCP), number of lesions, maximum diameter, peripheral hypoechoic halo, boundary, morphology, serrated edge, and internal necrosis between groups ( p < 0.05). TIC analysis showed significant differences in the ascending slope (AS), half of the decay time (DT/2), descending slope (DS) and area under the curve (AUC) between groups as well ( p < 0.05). Multivariate logistic regression analysis revealed that the number of lesions (OR = 3.845, 95% CI 1.315–11.248, p = 0.014), maximum diameter (OR = 1.064, 95% CI 1.030–1.098, p < 0.001), boundary (OR = 7.017, 95% CI 1.638–30.072, p = 0.009), and morphology (OR = 5.970, 95% CI 1.154–30.879, p = 0.03) were significantly correlated with Ki‐67 expression in HCC patients. DS was negatively correlated with Ki‐67 expression (OR = 0.000, 95% CI 0.000–0.108, p = 0.013). The AUC of the CEUS‐based prediction model was 0.949 (95% CI 0.906–0.992). Conclusions: CEUS images plus TIC analysis provide valuable information to predict preoperative Ki‐67 expression in HCC patients, thus favoring clinical management to improve patients' prognosis.Keywords
This publication has 20 references indexed in Scilit:
- Prognosis predictors of hepatocellular carcinoma after hepatectomy following conversion therapyEuropean Journal of Surgical Oncology, 2024
- Clinicopathologic features and tumor immune microenvironment of lymphocyte-rich hepatocellular carcinomaAnnals of Diagnostic Pathology, 2024
- A high Ki‐67 labeling index and high thyroglobulin doubling rate are significant predictors of excision‐site recurrence of papillary thyroid carcinoma following airway resection for locally curative surgeryWorld Journal of Surgery, 2024
- Oncological outcomes of tumor ablation compared to surgical resection in early-stage hepatocellular carcinomas: a systematic review with meta-analysisHPB, 2024
- Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resectionJournal of Hepatology, 2024
- Preoperative Contrast‐Enhanced Ultrasound Predicts Microvascular Invasion in Hepatocellular Carcinoma as Accurately as Contrast‐Enhanced MRJournal of Ultrasound in Medicine, 2023
- Dynamic Contrast-Enhanced Ultrasonography with Sonazoid for Diagnosis of Microvascular Invasion in Hepatocellular CarcinomaUltrasound in Medicine & Biology, 2022
- Contrast-enhanced Ultrasound—State of the Art in North AmericaUltrasound Quarterly, 2020
- Incorporation of p-53 mutation status and Ki-67 proliferating index in classifying Her2-neu positive gastric adenocarcinomaLibyan Journal of Medicine, 2018
- Preoperative gadoxetic acid–enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinomaJournal of Hepatology, 2017